Postday One-step Tablet
Product Images NDC 85506-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Postday One-step (NDC 85506-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Home Health Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Postday One-step (85506100 2)

Postday One-step (85506100 2)
This is a description of PostDay One-Step emergency contraceptive tablets containing 1.5 mg of Levonorgestrel. It is designed to be taken as soon as possible within 72 hours after unprotected sex to reduce the chance of pregnancy. The tablet is not meant for regular birth control. It is manufactured by Glenmark Pharmaceuticals Limited in India and distributed by HomeHealthBrands. The product works by preventing ovulation and may also prevent fertilization or implantation of a fertilized egg. It includes warnings about allergies, STD protection, and drug interactions. Possible side effects include menstrual changes, tiredness, breast pain, nausea, headache, vomiting, lower stomach pain, and dizziness. The product should be stored at 20-25°C and kept out of reach of children. If an overdose occurs, medical help should be sought immediately. Further information and contact details are provided for questions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.